Hormone therapy: Mica Peak Health

Perimenopause and menopause care that starts by believing you.

If you've been told it's "just aging," you've been talked past, not treated.

Hot flashesNight sweatsInsomniaMood swingsAnxietyBrain fogWeight gainLow libidoVaginal drynessHair & skin changes

You're not imagining it, and you're not alone. Your provider takes the full visit to listen, and builds the plan with you.

Comprehensive membership · $99/mo · labs & controlled prescribing included

What's included

Care that’s broader than hormones.

✓

Estrogen, progesterone, combined, or vaginal options, whichever your provider recommends

✓

Optional testosterone add-on for libido, energy, or lean-mass support

✓

Baseline labs when your provider orders them, included

✓

A named provider following your plan over time

Adding testosteroneAdding testosterone is a legitimate, commonly used option for libido and energy; it's off-label and controlled, so it always includes a live video visit.

On the patch shortageEstradiol patches have seen national shortages, so your provider plans around them (tablet or alternate brand) so you're never stranded.

Questions

Answered straight.

Will anyone actually listen?

That's the point of the model: one named provider, every visit, who already read your intake. You don't re-explain yourself to a stranger.

Is HRT safe, and what about the breast-cancer risk?

If you've heard "HRT causes breast cancer," that fear traces to a 2002 study that was broadly overcorrected. In November 2025 the FDA removed the breast-cancer, heart-disease, and dementia warnings from the boxed label. HRT isn't right for everyone, and your provider will be straight with you about your own risk profile.

The science

The 2002 Women's Health Initiative reported a relative breast-cancer increase (hazard ratio ≈ 1.26) for estrogen-plus-progestin, but in absolute terms that's roughly 9 extra cases per 10,000 women per year, and most participants were over 60, years past menopause. Longer follow-up and the "timing hypothesis" showed that women starting therapy in their 50s, within about 10 years of menopause, have a more favorable benefit–risk balance. On Nov 10, 2025 the FDA removed the boxed warnings for breast cancer, cardiovascular disease, and dementia; an endometrial-cancer warning remains for estrogen-only therapy in women with a uterus.

Source: FDA labeling change (Nov 2025) →Source: Reappraising 21 years of the WHI →

Is compounded "bioidentical" better?

Usually not. FDA-approved estradiol and progesterone are already bioidentical and first-line. Compounded forms are for specific cases, like an allergy to an ingredient or a dose that isn't commercially made, and we'll tell you which you are.

The science

In 2020 the National Academies (NASEM) reviewed compounded bioidentical hormone therapy for the FDA and found a lack of rigorous evidence of safety and effectiveness, citing concerns like inconsistent dosing, impurities, and no standardized label. The Menopause Society recommends FDA-approved hormones first, reserving compounded options for documented needs such as ingredient allergies or unavailable doses, the same standard we use.

Source: NASEM review for the FDA (2020) →Source: The Menopause Society →

What does the first month look like?

Intake → provider review (live visit where needed or preferred) → plan and prescription → check-in as you settle. Labs only if your plan needs a baseline, and those are included.

Educational, not medical advice. Medical & legal review pending before publishing.

Perimenopause and menopause care that starts by believing you.

Pick what's bothering you, and see how care meets it.

Care that’s broader than hormones.

Comprehensive: $99/mo

The real math. Nothing marked up.

One named provider, every visit, who already read your intake.

Answered straight.

Care that starts by believing you.